Rome, 3 Aug. (LaPresse) – The British pharmaceutical company AstraZeneca is reportedly in talks regarding a merger with its US rival Bristol Myers Squibb. The deal would create one of the world’s largest pharmaceutical groups, with a valuation of nearly $400 billion. This is according to the Financial Times. According to sources close to the matter, the companies have been discussing a possible merger in recent months. The talks could lead to an agreement shortly, but they could also be delayed or fall through
FT: ‘AstraZeneca in talks with Bristol Myers Squibb over mega-merger’
Follow us on
Rome, 3 Aug. (LaPresse) – The British pharmaceutical company AstraZeneca is reportedly in talks regarding a merger with its US rival Bristol Myers Squibb. The deal would create one of the world’s largest pharmaceutical groups, with a valuation of nearly $400 billion. This is according to the Financial Times. According to sources close to the matter, the companies have been discussing a possible merger in recent months. The talks could lead to an agreement shortly, but they could also be delayed or fall through
Powered by
© Riproduzione Riservata